Appeal No. 99-0624
Application 07/749,482
This is an appeal from the examiner’s final rejection of
claims 112-118, 120-122 and 128-131, which are all of the
claims remaining in the application.
THE INVENTION
Appellants’ claimed invention is directed toward
pharmaceutical compositions which are useful for $-lactamase
inhibition in humans and animals and which include clavulanic
acid or a pharmaceutically acceptable salt thereof, in
combination with a pharmaceutically acceptable carrier or in
pharmaceutically acceptable form. Claims 112 and 128 are
illustrative and read as follows:
112. A pharmaceutical composition useful for effecting
$-lactamase inhibition in humans and animals which comprises a
$-lactamase inhibitory amount of a pharmaceutically
acceptable salt of clavulanic acid, in combination with a
pharmaceutically acceptable carrier.
128. A $-lactamase inhibitory pharmaceutical composition
comprising solid clavulanic acid or a pharmaceutically
acceptable salt thereof in a $-lactamase inhibitory amount in
pharmaceutically acceptable form.
THE REFERENCE
Eli Lilly & Co. (Lilly) 1,315,177 Apr.
26, 1973
2
Page: Previous 1 2 3 4 5 6 Next
Last modified: November 3, 2007